Health and Healthcare
J&J Earnings: Size Does Matter (JNJ)
Published:
Last Updated:
Johnson & Johnson (NYSE: JNJ) is showing that some companies can get it right despite tough times. The company has beat earnings and is even raising its fiscal 2008 guidance. The consumer products and health care company posted earnings of $1.17 EPS compared to the First Call consensus of $1.11. It said that revenues rose 6.4% year over year to $15.92 billion, above the $15.69 billion consensus.
As a result of the quarter and as a result of its strength it now seesFiscal EPS of between $4.50 to 4.53 vs. $4.51 consensus and vs. $4.45 to$4.50 prior guidance.
Johnson & Johnson brand products are still selling well despitewhat the company called "the impact that generic products have had onour Pharmaceutical business." The company also said that strong salesperformance of its Consumer segment and solid sales results in MedicalDevices and Diagnostics segments.
There are some additional metrics which are very impressive when youconsider the penny pinching from the consumer. Worldwide Consumersales of $4.1 billion for the third quarter represented a 13.1%increase over the prior year with operational growth of 9.4% and apositive impact from currency of 3.7%. Domestic sales increased 11.2%,while international sales increased 14.7%; 8.1% from operations and6.6% from currency.
Shares closed at $62.68 yesterday and it is indicated around $65.00pre-market. J&J’s 52-week trading range is $52.06 to $72.76.
Jon C. Ogg
October 14, 2008
Retirement planning doesn’t have to feel overwhelming. The key is finding professional guidance—and we’ve made it easier than ever for you to connect with the right financial advisor for your unique needs.
Here’s how it works:
1️ Answer a Few Simple Questions
Tell us a bit about your goals and preferences—it only takes a few minutes!
2️ Get Your Top Advisor Matches
This tool matches you with qualified advisors who specialize in helping people like you achieve financial success.
3️ Choose Your Best Fit
Review their profiles, schedule an introductory meeting, and select the advisor who feels right for you.
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.